ArticleClinical kidney journal2024

Tenapanor in Chinese ESRD patients with hyperphosphatemia on haemodialysis: a randomised, phase 3 trial.

Liangying Gan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.